Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●(See "Society guideline links: Gastroesophageal reflux in adults".)
●(See "Society guideline links: Eosinophilic esophagitis".)
●(See "Society guideline links: Esophageal manometry and pH testing".)
●(See "Society guideline links: Barrett's esophagus".)
International
●World Gastroenterology Organization (WGO): Practice guideline – Gastroesophageal reflux disease (GERD), update (2015)
●A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population (2009)
●International Pediatric Endosurgery Group (IPEG): Guidelines for the surgical treatment of pediatric gastroesophageal reflux disease (GERD) (2009)
Canada
●Choosing Wisely Canada: Don't maintain long term Proton Pump Inhibitor (PPI) therapy for gastrointestinal symptoms without an attempt to stop/reduce PPI at least once per year in most patients (2021)
●Choosing Wisely Canada: Don't routinely use acid blockers or motility agents for the treatment of gastroesophageal reflux in infants (2021)
●North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN): Pediatric gastroesophageal reflux clinical practice guidelines (2018)
United States
●Society of American Gastrointestinal and Endoscopic Surgeons (SAGES): Guidelines for surgical treatment of gastroesophageal reflux disease (GERD) (2021)
●American College of Chest Physicians (CHEST): Guideline and expert panel report on chronic cough and gastroesophageal reflux in children (2019)
●American Academy of Pediatrics (AAP): Clinical report on the diagnosis and management of gastroesophageal reflux in preterm infants (2018)
●North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN): Pediatric gastroesophageal reflux clinical practice guidelines (2018)
●AAP: Clinical practice guideline on brief resolved unexplained events (formerly apparent life-threatening events) and evaluation of lower-risk infants (2016)
●AAP: Clinical report on gastroesophageal reflux – Management guidance for the pediatrician (2013)
Europe
●North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN): Pediatric gastroesophageal reflux clinical practice guidelines (2018)
●European Association of Endoscopic Surgery (EAES): Recommendations for the management of gastroesophageal reflux disease (2014)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Guideline for gastro-oesophageal reflux disease in children and young people – Diagnosis and management (2015, updated 2019)
●NICE: Quality standard on gastro-oesophageal reflux in children and young people (2016)
Australia–New Zealand
●Choosing Wisely Australia: Do not routinely treat gastroesophageal reflux disease (GORD) in infants with acid suppression therapy (2017)
●Choosing Wisely Australia: Do not continue prescribing long term proton pump inhibitor (PPI) medication to patients without attempting to reduce the medication down to the lowest effective dose or cease the therapy altogether (2016)
●Choosing Wisely Australia: Don't use proton pump inhibitors (PPIs) long term in patients with uncomplicated disease without regular attempts at reducing dose or ceasing (2015)
Japan
●Japanese Society of Gastroenterology (JSG): Evidence-based clinical practice guidelines for gastroesophageal reflux disease, 2021 (2022)
